InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (4 ops.)
Discover the full record of transactions filed by Skolnick Phil, Directeur Scientifique. Insider active across 1 company, notably Opiant Pharmaceuticals, INC.. Cumulatively, 7 reports have been published. Breakdown: 0 buy · 4 sells. Total volume traded: €91k. Activity tracked since 4 January 2022. The latest transaction was disclosed on 27 June 2022 (Attribution). Regulator: SEC (Form 4). The full history is free.
Declarations7 total
2,000 shares0Common StockSEC:0001385508-22-000101:0
1,518 shares@ US$26.1938.7% of flowCommon StockSEC:0001385508-22-000026:0
1,518 shares@ US$26.1977.4% of flowCommon StockSEC:0001385508-22-000026
385 shares@ US$30.4922.6% of flowCommon StockSEC:0001385508-22-000021
385 shares@ US$30.4911.3% of flowCommon StockSEC:0001385508-22-000021:0
12,000 shares0Common StockSEC:0001385508-22-000013
12,000 shares0Common StockSEC:0001385508-22-000013:0
7 of 7 declarations
About Skolnick Phil
Phil Skolnick is Chief Scientific Officer at Opiant Pharmaceuticals, Inc. He is responsible for the scientific direction of the company, overseeing research and development of new products. His expertise is essential for innovation and the success of Opiant Pharmaceuticals.
